Huadong Medicine announces 2025 interim cash dividend of 3.50 yuan per 10 shares

Huadong Medicine Co., Ltd. has announced the implementation of its 2025 semi-annual equity distribution. The company will distribute a cash dividend of 3.50 yuan per 10 shares (including tax) to all shareholders, totaling 613,907,366.80 yuan. This distribution is based on the company's total share capital of 1,754,021,048.00 shares, after deducting 56,000.00 repurchased and uncancelled restricted shares.

The mid-term dividend amount is capped at 50% of the net profit attributable to shareholders and a minimum of 500 million yuan (including tax). The equity registration date for this distribution is September 17, 2025, with the ex-dividend and payment date set for September 18, 2025.

For Hong Kong market investors and foreign institutions (including QFII and RQFII) holding shares via Stock Connect, the cash dividend will be 3.15 yuan per 10 shares after tax. Individual shareholders holding shares after the initial public offering, restricted shares from equity incentives, and unrestricted circulating shares will be subject to differentiated tax rates. Huadong Medicine will not withhold individual income tax at this time, with the tax calculated based on the holding period when shares are transferred.